Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
If you have any specific product queries, please contact the manufacturer
The molecular target that AOD-9604 actually binds is still unidentified, which the FDA explicitly noted in its December 2024 evaluation
Italy Research suggests that AOD-9604 may stimulate lipolysis (the breakdown of stored fat) and inhibit lipogenesis (the formation of new fat), making it of interest for body composition and weight management applications
Since they contain the same active ingredient, healthcare professionals can use the manufacturer's guidance to determine the most appropriate starting dose when switching between formulations
After transfection, the cells were plated in DMEM with 5% FBS and 400 mg/mL G418 for a month
